PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Astrocytoma D001254 15 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Dyskinesia, Drug-Induced D004409 15 associated lipids
HIV Seropositivity D006679 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Encephalitis D004660 15 associated lipids
Blister D001768 16 associated lipids
Adenomatous Polyposis Coli D011125 16 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Sinzinger H et al. Isradipine improves platelet function in hypertensives. 1992 Eur. J. Clin. Pharmacol. pmid:1531796
Ito S et al. Type-1 and type-2 astrocytes are distinct targets for prostaglandins D2, E2, and F2 alpha. 1992 Glia pmid:1324890
Tsukagoshi H and Kurosawa M [Bronchial hyperresponsiveness to histamine induced by intravenous administration of prostaglandin D2 (PGD2) in guinea pigs]. 1992 Nippon Yakurigaku Zasshi pmid:1559641
Magnussen H et al. Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction. 1992 J. Allergy Clin. Immunol. pmid:1535083
Campbell AM et al. In vitro activation of bronchoalveolar lavage cells by house dust mite allergens. 1992 Ann Allergy pmid:1371209
Mitsuoka S et al. Inhibitory effect of prostaglandin delta 12-PGJ2 on cell proliferation and alpha-fetoprotein expression in HuH-7 human hepatoma cells. 1992 Prostaglandins pmid:1371888
Yen A et al. Protoporphyrin and long-wave ultraviolet light modulate metabolic events in rat peritoneal mast cells. 1992 J. Invest. Dermatol. pmid:1372341
Stellato C et al. Anti-inflammatory effect of cyclosporin A on human skin mast cells. 1992 J. Invest. Dermatol. pmid:1373749
Katz HR et al. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. 1992 J. Immunol. pmid:1309842
Morrow JD et al. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. 1992 J. Invest. Dermatol. pmid:1373750
Okayama Y et al. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. 1992 Clin. Exp. Allergy pmid:1375128
Okayama Y and Church MK Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. 1992 Int. Arch. Allergy Immunol. pmid:1375203
Smith JB et al. Cyclic AMP does not inhibit collagen-induced platelet signal transduction. 1992 Biochem. J. pmid:1375452
Ikai K et al. Induction of 72-kD heat shock protein and cytoskeleton damage by cytotoxic prostaglandin delta 12-PGJ2 in transformed human epidermal cells in culture. 1992 J. Invest. Dermatol. pmid:1375619
Yu SM et al. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. 1992 Biochem. Pharmacol. pmid:1310852
Lippton HL et al. Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed. 1992 Am. J. Physiol. pmid:1348400
Crea AE et al. Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma. 1992 Eur. Respir. J. pmid:1348480
Shin MH et al. The effect of azelastine on the early allergic response. 1992 Clin. Exp. Allergy pmid:1349259
Molderings G et al. Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype. 1992 Br. J. Pharmacol. pmid:1330175
Mulkins MA et al. Mycophenolic acid inhibits the degranulation of rat peritoneal mast cells. 1992 Cell. Immunol. pmid:1349511
Conti P et al. Role of lipoxins A4 and B4 in the generation of arachidonic acid metabolites by rat mast cells and their effect on [3H]serotonin release. 1992 Immunol. Lett. pmid:1612634
Björnsson OG et al. Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures: relationships to hepatic calcium metabolism. 1992 J. Lipid Res. pmid:1331281
Columbo M et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. 1992 J. Immunol. pmid:1378071
Goerg KJ et al. Inhibition of neuronally mediated secretion in rat colonic mucosa by prostaglandin D2. 1992 Gastroenterology pmid:1379954
Charlesworth EN et al. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. 1992 J. Pharmacol. Exp. Ther. pmid:1382132
Murakami M et al. Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process. 1992 Eur. J. Biochem. pmid:1382985
Johnston SL et al. The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations. 1992 Br J Clin Pharmacol pmid:1467134
Lin CH et al. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. 1992 Thromb. Res. pmid:1412184
Koizumi T et al. Inhibitory effect of an intracellular glutathione on delta 12-prostaglandin J2-induced protein syntheses in porcine aortic endothelial cells. 1992 Biochem. Pharmacol. pmid:1417983
Norwitz ER et al. Prostaglandin D2 production by term human decidua: cellular origins defined using flow cytometry. 1992 Obstet Gynecol pmid:1495703
Sasaguri T et al. Anti-proliferative effect of prostaglandins A and J on cultured vascular smooth muscle cells. 1992 Jpn. J. Pharmacol. pmid:1507558
Hoshi A et al. [Experimental study on the role of prostaglandin D2 in the pathogenesis of bronchial asthma]. 1992 Nihon Kyobu Shikkan Gakkai Zasshi pmid:1507684
Bacic F et al. Prostaglandin D2 in cultured capillary and microvascular endothelium of human brain. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1508957
Thomas PS et al. Prostaglandin D2 production and identification of prostaglandin H synthase within canine mast cell granule. 1992 Am. J. Physiol. pmid:1514641
Kaiser L et al. Dirofilaria immitis: do filarial cyclooxygenase products depress endothelium-dependent relaxation in the in vitro rat aorta? 1992 Exp. Parasitol. pmid:1516664
Braun M and Schrör K Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. 1992 Circ. Res. pmid:1385004
Emery BE et al. The effect of IL-4 on human nasal mucosal responses. 1992 J. Allergy Clin. Immunol. pmid:1430703
Barrett KE Effect of histamine and other mast cell mediators on T84 epithelial cells. 1992 Ann. N. Y. Acad. Sci. pmid:1456653
Diener M et al. Characterization of the antisecretory action of prostaglandin D2 in the rat colon. 1992 Acta Physiol. Scand. pmid:1502910
Virgolini I et al. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor. 1992 J. Biol. Chem. pmid:1377673
Watanabe-Kohno S et al. MCI-826 is a potent and selective antagonist of peptide leukotrienes (p-LTs) and has characteristics distinctive from those of FPL 55712. 1992 Jpn. J. Pharmacol. pmid:1460800
Shimakura S and Boland CR Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth. 1992 Cancer Res. pmid:1551103
Lee DY et al. Prostaglandin profile and synthetic capacity of the colon: comparison of tissue sources and subcellular fractions. 1992 Prostaglandins pmid:1542741
Picado C et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. 1992 Am. Rev. Respir. Dis. pmid:1309968
Kawada N et al. Possible induction of fatty acid cyclo-oxygenase in lipopolysaccharide-stimulated rat Kupffer cells. 1992 Gastroenterology pmid:1499903
Koizumi T et al. Induction of heme oxygenase by delta 12-prostaglandin J2 in porcine aortic endothelial cells. 1992 Prostaglandins pmid:1542739
Rangachari PK Concerning prostaglandin D2: forgotten, promiscuous, capricious. 1992 Ann. N. Y. Acad. Sci. pmid:1456655
D'Onofrio C et al. Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells. 1992 Int. J. Cancer pmid:1592539
Wang D et al. Terbutaline acts at multiple sites to inhibit bronchoconstriction induced by dry air in canine peripheral airways. 1992 Am. Rev. Respir. Dis. pmid:1595994
Hogaboam CM et al. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. 1992 Br. J. Pharmacol. pmid:1596692